"The one fund in the top 20 that isn't tied to energy, crypto or chips is the ARK Genomic Revolution ETF (ARKG), up 87%. Biotech has had a strong year, fueled by a wave of dealmaking and positive clinical data, and ARKG's concentrated portfolio of smaller genomics companies has amplified that rally."
- Sumit Roy,
Learn about ARKG: